elanco animal health uk limited
elanco animal health uk limited Company Information
Company Number
02703014
Website
http://novartis.co.ukRegistered Address
form 2 bartley way, bartley wood business park, hook, RG27 9XA
Industry
Manufacture of other chemical products n.e.c.
Telephone
01256353131
Next Accounts Due
September 2025
Group Structure
View All
Shareholders
eli lilly & company limited 100%
elanco animal health uk limited Estimated Valuation
Pomanda estimates the enterprise value of ELANCO ANIMAL HEALTH UK LIMITED at £0 based on a Turnover of £0 and 0.56x industry multiple (adjusted for size and gross margin).
elanco animal health uk limited Estimated Valuation
Pomanda estimates the enterprise value of ELANCO ANIMAL HEALTH UK LIMITED at £0 based on an EBITDA of £0 and a 4.09x industry multiple (adjusted for size and gross margin).
elanco animal health uk limited Estimated Valuation
Pomanda estimates the enterprise value of ELANCO ANIMAL HEALTH UK LIMITED at £2 based on Net Assets of £1 and 2.06x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Elanco Animal Health Uk Limited Overview
Elanco Animal Health Uk Limited is a live company located in hook, RG27 9XA with a Companies House number of 02703014. It operates in the manufacture of other chemical products n.e.c. sector, SIC Code 20590. Founded in April 1992, it's largest shareholder is eli lilly & company limited with a 100% stake. Elanco Animal Health Uk Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Elanco Animal Health Uk Limited Health Check
There is insufficient data available to calculate a health check for Elanco Animal Health Uk Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Elanco Animal Health Uk Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Elanco Animal Health Uk Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Elanco Animal Health Uk Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Elanco Animal Health Uk Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Elanco Animal Health Uk Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Elanco Animal Health Uk Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Elanco Animal Health Uk Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Elanco Animal Health Uk Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Elanco Animal Health Uk Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Elanco Animal Health Uk Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Elanco Animal Health Uk Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Elanco Animal Health Uk Limited
- - Industry AVG
ELANCO ANIMAL HEALTH UK LIMITED financials
Elanco Animal Health Uk Limited's latest turnover from December 2023 is estimated at 0 and the company has net assets of £1. According to their latest financial statements, we estimate that Elanco Animal Health Uk Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 62,717,000 | 68,977,000 | 69,110,000 | 56,983,000 | 53,267,000 | 54,347,000 | 52,019,000 | ||||||||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
| Cost Of Sales | 43,109,000 | 42,491,000 | 40,279,000 | 33,446,000 | 29,670,000 | 29,854,000 | 28,101,000 | ||||||||
| Gross Profit | 19,608,000 | 26,486,000 | 28,831,000 | 23,537,000 | 23,597,000 | 24,493,000 | 23,918,000 | ||||||||
| Admin Expenses | 94,231,000 | 21,263,000 | 22,754,000 | 19,909,000 | 17,570,000 | 18,983,000 | 18,346,000 | ||||||||
| Operating Profit | -74,623,000 | 5,223,000 | 6,077,000 | 3,628,000 | 6,027,000 | 5,510,000 | 5,572,000 | ||||||||
| Interest Payable | 135,000 | 259,000 | 356,000 | 373,000 | 381,000 | 369,000 | 161,000 | ||||||||
| Interest Receivable | 11,000 | 39,000 | 51,000 | 62,000 | 72,000 | 56,000 | 3,000 | ||||||||
| Pre-Tax Profit | -74,747,000 | 5,003,000 | 5,772,000 | 3,317,000 | 5,718,000 | 5,197,000 | 5,414,000 | ||||||||
| Tax | 3,546,000 | -1,106,000 | -1,321,000 | -700,000 | -1,354,000 | -1,344,000 | -1,578,000 | ||||||||
| Profit After Tax | -71,201,000 | 3,897,000 | 4,451,000 | 2,617,000 | 4,364,000 | 3,853,000 | 3,836,000 | ||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 5,000,000 | 0 | ||||||||
| Retained Profit | -71,201,000 | 3,897,000 | 4,451,000 | 2,617,000 | 4,364,000 | -1,147,000 | 3,836,000 | ||||||||
| Employee Costs | 22,137,000 | 13,740,000 | 13,503,000 | 12,256,000 | 10,065,000 | 10,289,000 | 9,811,000 | ||||||||
| Number Of Employees | 117 | 156 | 176 | 170 | 158 | 145 | 151 | ||||||||
| EBITDA* | -74,623,000 | 5,226,000 | 6,083,000 | 3,639,000 | 6,044,000 | 5,529,000 | 5,591,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,000 | 50,000 | 56,000 | 67,000 | 23,660,000 | 24,606,000 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23,485,000 | 23,485,000 | 23,485,000 | 24,376,000 | 23,485,000 | 23,485,000 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 835,000 | 1,219,000 | 359,000 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24,324,000 | 24,754,000 | 23,900,000 | 24,443,000 | 23,660,000 | 24,606,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21,967,000 | 8,325,000 | 8,156,000 | 7,008,000 | 5,774,000 | 6,540,000 | 6,257,000 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,017,000 | 8,256,000 | 8,217,000 | 6,586,000 | 6,226,000 | 7,323,000 | 4,902,000 |
| Group Debtors | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1,495,000 | 2,129,000 | 19,062,000 | 14,096,000 | 17,881,000 | 14,535,000 | 12,969,000 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 442,000 | 1,529,000 | 943,000 | 938,000 | 592,000 | 488,000 | 611,000 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11,598,000 | 806,000 | 0 | 0 | 1,035,000 | 1,009,000 | 3,010,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,531,000 | 27,000 | 134,000 | 175,000 | 229,000 | 0 | 0 |
| total current assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 49,050,000 | 21,072,000 | 36,512,000 | 28,803,000 | 31,737,000 | 29,895,000 | 27,749,000 |
| total assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 49,050,000 | 45,396,000 | 61,266,000 | 52,703,000 | 56,180,000 | 53,555,000 | 52,355,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29,858,000 | 8,400,000 | 139,000 | 193,000 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 441,000 | 651,000 | 707,000 | 1,500,000 | 255,000 | 921,000 | 541,000 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20,034,000 | 8,108,000 | 30,260,000 | 28,076,000 | 28,521,000 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,834,000 | 7,094,000 | 8,283,000 | 6,102,000 | 7,044,000 | 31,522,000 | 30,196,000 |
| total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 57,167,000 | 24,253,000 | 39,389,000 | 35,871,000 | 35,820,000 | 32,443,000 | 30,737,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,838,000 | 5,682,000 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,528,000 | 10,395,000 | 5,661,000 | 4,362,000 | 919,000 | 2,841,000 |
| total liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 57,167,000 | 27,781,000 | 49,784,000 | 41,532,000 | 40,182,000 | 33,362,000 | 33,578,000 |
| net assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | -8,117,000 | 17,615,000 | 11,482,000 | 11,171,000 | 15,998,000 | 20,193,000 | 18,777,000 |
| total shareholders funds | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | -8,117,000 | 17,615,000 | 11,482,000 | 11,171,000 | 15,998,000 | 20,193,000 | 18,777,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -74,623,000 | 5,223,000 | 6,077,000 | 3,628,000 | 6,027,000 | 5,510,000 | 5,572,000 | ||||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 3,000 | 6,000 | 11,000 | 17,000 | 19,000 | 19,000 | |||
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Tax | 3,546,000 | -1,106,000 | -1,321,000 | -700,000 | -1,354,000 | -1,344,000 | -1,578,000 | ||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -21,967,000 | 13,642,000 | 169,000 | 1,148,000 | 1,234,000 | -766,000 | 283,000 | 6,257,000 |
| Debtors | 0 | 0 | 0 | 0 | 1 | 0 | 0 | -11,954,000 | -795,000 | -16,692,000 | 7,462,000 | -2,720,000 | 2,353,000 | 3,864,000 | 18,482,000 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -441,000 | -210,000 | -56,000 | -793,000 | 1,245,000 | -666,000 | 380,000 | 541,000 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6,834,000 | -260,000 | -1,189,000 | 2,181,000 | -942,000 | -24,478,000 | 1,326,000 | 30,196,000 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,838,000 | -3,844,000 | 5,682,000 |
| Cash flow from operations | -84,394,000 | 19,398,000 | -2,460,000 | 4,728,000 | -23,879,000 | -2,100,000 | 15,693,000 | ||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23,485,000 | 0 | 0 | -891,000 | 891,000 | 0 | 23,485,000 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20,034,000 | 11,926,000 | -22,152,000 | 2,184,000 | -445,000 | 28,521,000 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | -124,000 | -220,000 | -305,000 | -311,000 | -309,000 | -313,000 | -158,000 | ||||||||
| cash flow from financing | 57,271,000 | -20,136,000 | -2,261,000 | -8,200,000 | 19,653,000 | 2,250,000 | 14,783,000 | ||||||||
| cash and cash equivalents | |||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11,598,000 | 10,792,000 | 806,000 | 0 | -1,035,000 | 26,000 | -2,001,000 | 3,010,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -29,858,000 | 21,458,000 | 8,261,000 | -54,000 | 193,000 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18,260,000 | -10,666,000 | -7,455,000 | 54,000 | -1,228,000 | 26,000 | -2,001,000 | 3,010,000 |
elanco animal health uk limited Credit Report and Business Information
Elanco Animal Health Uk Limited Competitor Analysis
Perform a competitor analysis for elanco animal health uk limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mature companies, companies in RG27 area or any other competitors across 12 key performance metrics.
elanco animal health uk limited Ownership
ELANCO ANIMAL HEALTH UK LIMITED group structure
Elanco Animal Health Uk Limited has no subsidiary companies.
Ultimate parent company
ELI LILLY & CO
#0000729
2 parents
ELANCO ANIMAL HEALTH UK LIMITED
02703014
elanco animal health uk limited directors
Elanco Animal Health Uk Limited currently has 2 directors. The longest serving directors include Mr Christopher Lewis (Aug 2018) and Mrs Kristina Hunt (Dec 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Christopher Lewis | England | 46 years | Aug 2018 | - | Director |
| Mrs Kristina Hunt | England | 55 years | Dec 2018 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
1
0%
total assets
1
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
elanco animal health uk limited company details
company number
02703014
Type
Private limited with Share Capital
industry
20590 - Manufacture of other chemical products n.e.c.
incorporation date
April 1992
age
32
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
December 2023
previous names
novartis animal health uk limited (December 2017)
sandoz speciality pest control limited (January 1997)
accountant
-
auditor
-
address
form 2 bartley way, bartley wood business park, hook, RG27 9XA
Bank
HSBC BANK PLC
Legal Advisor
-
elanco animal health uk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to elanco animal health uk limited.
elanco animal health uk limited Companies House Filings - See Documents
| date | description | view/download |
|---|
